ClinicalTrials.gg
Status unknownNCT00299637Updated Nov 30, 2006

Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis

An observational study in Chorioamnionitis, sponsored by Hadassah Medical Organization. Status unknown at 1 site in Israel. Open to female participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2006-11-30.

Sponsored by Hadassah Medical Organization · Observational

The sponsor has not verified this record recently (last verified Mar 2006), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Other
Enrollment
34
Ages
20 Years to 45 Years
Sex
Female
01

Study summary

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

Read the detailed description

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

MCA flow parameters will be evaluated during labor of women with and wthout chorioamnionitis

02

Conditions studied

  • Chorioamnionitis

Browse trials for

03

In context

Chorioamnionitis

39 studies on the registry are indexed under Chorioamnionitis; 9 are open to participants now.

This study's planned enrollment of 34 is below the median of 125 across 14 observational studies indexed under Chorioamnionitis.

Browse Chorioamnionitis studies →

Lead sponsor

Hadassah Medical Organization is the lead sponsor of 675 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women giving birth week 37-42
  • healthy
  • one fetus

Exclusion criteria

Exclusion Criteria:

  • more than one fetus
  • IUGR
  • illness or damage to fetus
05

Study design

Observational model
Case-control
Time perspective
Other
Enrollment
34 participants (estimated)
06

Study locations

1 of 1 sites recruiting
  • Haddasah Medical Organization
    Jerusalem, 12000, Israel
    Recruiting
    • David Mankuta · Contact
    • David Mankuta · Principal investigator
07

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2006 and a completion of Dec 2007. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2006
First posted
Mar 7, 2006
Start
Oct 2006
CompletionEst.
Dec 2007
Last update
Nov 30, 2006
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 30, 2006, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00299637
First posted
Mar 7, 2006
Start date
Oct 2006
Completion
Dec 2007 (estimated)
Last update
Nov 30, 2006

Study contacts

david mankuta, MD
Contact
mankuta@yahoo.com
David Mankuta, MD
study chair · Hadassah Medical Organization
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion